Novo Nordisk or Eli Lilly? The GLP-1 Battle That’s Reshaping Healthcare
The global market for GLP-1 medicines continues to attract significant attention from patients, healthcare professionals, investors, and pharmaceutical companies. Novo Nordisk …
